Restricted Access

Before you enter

All products are sold strictly for in-vitro laboratory research — not for human consumption, therapeutic, or veterinary use.

Your confirmation is saved for 7 days. You will only be asked to confirm once per week.
By entering you accept full responsibility for compliance with all applicable laws.

For research use only  ·  Not for human or animal consumption
KPV research vial Third-party tested
Cellular Peptide

KPV

Lysine-Proline-Valine
Alpha-MSH (11-13)α-MSH C-Terminal Fragment CAS 67727-97-3 Lys-Pro-Val

A tripeptide (Lys-Pro-Val) from the C-terminus of α-MSH, studied for inflammatory signaling in cell and animal models.

$20.00$4.00 / mg
Strength

Availability: 10 in stock

Fast U.S. shippingFree on orders over $200
Third-party testedIndependent lab, every batch
Purity documentedHPLC + mass spec
Secure checkoutVenmo · Cash App · Zelle
01Research snapshot

KPV, by the numbers.

Structural and laboratory facts that define this compound. For laboratory research use only.

0
Amino acid residues

Lys-Pro-Val tripeptide

0
Molecular weight

g/mol · C16H30N4O4

0–13
α-MSH positions

C-terminal tripeptide of α-MSH

0%+
Target purity

Reverse-phase HPLC

02Molecular structure

The KPV molecule

A schematic atomic representation shown next to the compound's molecular data. The figure is illustrative, not a measured conformation.

CHNOS
Molecular formula
C16H30N4O4
Mol. weight342.4 g/mol
Sequence length3 residues
CAS67727-97-3
Physical formLyophilized powder
Purity99%+ HPLC
Use classResearch only
LysProVal
03Mechanism of action

How it is studied.

An α-MSH-derived tripeptide studied across inflammatory signaling, intestinal inflammation, and wound-healing research models

01
NF-κB Inhibition Inflammatory Pathway Suppression

At nanomolar concentrations, KPV inhibits activation of the NF-κB and MAP-kinase inflammatory signaling pathways. By blunting NF-κB — a master regulator of inflammatory gene expression — KPV reduces secretion of pro-inflammatory cytokines such as TNF-α, IL-6 and IL-1β.

  • Inhibits NF-κB and MAP-kinase signaling at nanomolar levels
  • Reduces TNF-α, IL-6, IL-1β and other pro-inflammatory cytokines
  • Suppresses inflammatory output rather than boosting anti-inflammatory cytokines
02
PepT1-Mediated Uptake Cellular Transport & Action

Research shows KPV is taken up by cells via the PepT1 di/tripeptide transporter, which is expressed on immune cells and intestinal epithelial cells. This transporter-mediated uptake allows KPV to act intracellularly on inflammatory signaling.

  • Enters cells through the PepT1 peptide transporter
  • PepT1 is expressed on immune and intestinal epithelial cells
  • Enables intracellular modulation of inflammatory pathways
03
α-MSH-Derived Activity Melanocortin Fragment

KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone (α-MSH 11–13). Research indicates most of α-MSH's anti-inflammatory activity can be attributed to this fragment, which also shows antimicrobial activity in published studies.

  • C-terminal tripeptide of the melanocortin peptide α-MSH
  • Carries much of α-MSH's anti-inflammatory activity
  • Antimicrobial effects reported against S. aureus and C. albicans

Research pathway map

The primary pathways KPV is investigated against in laboratory models.

KPVTARGETS01NF-κB Inhibition02PepT1-Mediated Uptake03α-MSH-Derived Activity
Illustrative schematic based on published in-vitro and preclinical observations. Research use only.
04Specifications

Compound details.

Chemical nameLysyl-prolyl-valine (α-MSH 11–13)
SynonymsLysine-Proline-Valine, Alpha-MSH (11-13), α-MSH C-Terminal Fragment
SequenceLys-Pro-Val
FormulaC16H30N4O4
Molecular weight342.4 g/mol
CAS number67727-97-3
FormLyophilized powder
DocumentationThird-party COA, per batch

Storage & handling

Supplied as a lyophilized powder. Store the sealed vial refrigerated at 2–8°C, protected from light and moisture; −20°C for long-term storage. Keep reconstituted material refrigerated.

FOR RESEARCH USE ONLYNot for human or animal consumption. Intended strictly for qualified researchers performing in-vitro or analytical laboratory work. No medical, diagnostic or therapeutic claims are made.
Gastroenterology · 2008PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation

PepT1 uptake and inflammation models.

Dalmasso G et al., 2008 · PubMed ↗
Inflamm Bowel Dis · 2008Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease

Murine colitis models.

Kannengiesser K et al., 2008 · PubMed ↗
Trends Pharmacol Sci · 2002Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy

Review of anti-inflammatory melanocortin research.

Getting SJ, 2002 · PubMed ↗
0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Scroll to Top